ストックスクリーナーアプリを入手
2.0159
2.33%
0.0459
前日終値:
$1.97
開ける：
$1.99
24時間の取引高:
26,269
Relative Volume:
0.31
時価総額：
$7.61M
収益：
-
当期純損益:
$-6.24M
株価収益率:
-0.3609
EPS:
-5.5853
ネットキャッシュフロー:
$-8.09M
1週間 パフォーマンス:
+23.67%
1か月 パフォーマンス:
-8.37%
6か月 パフォーマンス:
-19.04%
1年 パフォーマンス:
-76.61%
1日の値動き範囲:
$1.95
$2.02
1週間の範囲:
$1.58
$2.06
52週間の値動き範囲:
$1.58
$10.17
Alzamend Neuro Inc Stock (ALZN) Company Profile
Compare ALZN vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.0008 | 7.49M | 0 | -6.24M | -8.09M | -5.5853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.34 | 121.15B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
788.00 | 82.43B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
835.28 | 52.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.95 | 44.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
367.28 | 40.07B | 4.98B | 69.60M | 525.67M | 0.5198 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-01 | 開始されました | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc (ALZN) 最新ニュース
How risky is Alzamend Neuro Inc. stock now2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - mfd.ru
Can Alzamend Neuro Inc. stock hit record highs againMarket Activity Report & Verified Trade Idea Suggestions - mfd.ru
Is Alzamend Neuro Inc. benefiting from interest rate changesEarnings Overview Report & Daily Price Action Insights - mfd.ru
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Will Alzamend Neuro Inc. announce a stock splitJuly 2025 Chart Watch & Fast Momentum Entry Tips - mfd.ru
What’s the fair value of Alzamend Neuro Inc. stockQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - mfd.ru
Alzamend Neuro (NASDAQ:ALZN) Stock Price Down 0.5% – Here’s Why - Defense World
Earnings Update: What is Alzamend Neuro Incs TAM Total Addressable MarketJuly 2025 Earnings & Technical Pattern Recognition Alerts - baoquankhu1.vn
EPS Watch: What is Alzamend Neuro Incs TAM Total Addressable MarketJuly 2025 Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Community Health Systems Incs ROE strong enough2025 Biggest Moves & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is Alzamend Neuro Inc. stock heavily shortedWeekly Profit Analysis & Daily Profit Maximizing Tips - bollywoodhelpline.com
Aug Sectors: Is Alzamend Neuro Inc stock heavily shortedJuly 2025 News Drivers & Weekly High Return Opportunities - baoquankhu1.vn
Bond Watch: Can Alzamend Neuro Inc stock beat market expectations this quarterQuarterly Growth Report & Capital Protection Trade Alerts - Bộ Nội Vụ
Alzamend Neuro (NASDAQ:ALZN) Stock Price Down 2.5% – Should You Sell? - Defense World
Can Alzamend Neuro Inc. stock beat analyst upgradesJuly 2025 Outlook & Safe Entry Point Identification - ulpravda.ru
ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Will Alzamend Neuro Inc. stock attract ESG investorsJuly 2025 Outlook & Precise Swing Trade Entry Alerts - Улправда
Will Alzamend Neuro Inc. stock return to pre crisis levelsJuly 2025 Short Interest & Safe Entry Zone Tips - ulpravda.ru
What technical charts say about Alzamend Neuro Inc. stockQuarterly Performance Summary & Reliable Price Breakout Alerts - ulpravda.ru
Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Alzamend Neuro, Inc.Common Stock (NQ: ALZN - FinancialContent
Momentum Shift: Will Alzamend Neuro Inc stock attract ESG investorsEarnings Performance Report & Stepwise Trade Signal Implementation - Bộ Nội Vụ
Ascendiant Sticks to Their Buy Rating for Alzamend Neuro (ALZN) - The Globe and Mail
Ascendiant Capital Maintains Alzamend Neuro (ALZN) Buy Recommendation - Nasdaq
ALZN: Ascendiant Capital Lowers Price Target, Maintains Buy Rati - GuruFocus
Decliners Report: Why Alzamend Neuro Inc. stock is recommended by analystsQuarterly Market Review & Detailed Earnings Play Strategies - Улправда
Will Alzamend Neuro Inc. stock deliver long term returnsWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
Is Alzamend Neuro Inc. stock attractive for ETFs2025 Support & Resistance & Community Verified Trade Signals - Улправда
Can Alzamend Neuro Inc. stock maintain growth trajectoryWeekly Trade Analysis & Risk Managed Trade Strategies - DonanımHaber
Alzamend Neuro Earnings Notes - Trefis
Why Alzamend Neuro Inc. stock is recommended by analystsQuarterly Growth Report & Verified Momentum Watchlists - Улправда
Can Alzamend Neuro Inc. stock sustain market leadershipJuly 2025 Chart Watch & Consistent Return Investment Signals - Улправда
Alzamend Neuro, Inc. SEC 10-Q Report - TradingView
Is Alzamend Neuro Inc stock attractive for passive investorsWeekly Investment Summary & Weekly Top Gainers Alerts - BỘ NỘI VỤ
Why Alzamend Neuro Inc. stock remains undervaluedJuly 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
Alzamend Neuro (ALZN) Stock Analysis Report | Financials & Insights - Benzinga
Alzamend Neuro Mourns Loss of Director Andrew Woo - MSN
Is Alzamend Neuro Inc. stock attractive for passive investors2025 Earnings Impact & Daily Profit Focused Stock Screening - BỘ NỘI VỤ
Alzamend Neuro: Will Topline Data Spark Investor Interest? - RTTNews
Alzamend Neuro's AL001 formulation highlights its potential to treat disorders such a Alzheimer's - SelectScience
What margin trends mean for Alzamend Neuro Inc. stockWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com
Why Alzamend Neuro Inc. stock could see breakout soonProduct Launch & High Return Trade Opportunity Guides - newser.com
Why Alzamend Neuro Inc. stock could benefit from AI revolutionTrade Risk Report & Daily Profit Maximizing Tips - newser.com
Can Alzamend Neuro Inc. stock sustain revenue growthMarket Risk Analysis & Pattern Based Trade Signal System - newser.com
Will Alzamend Neuro Inc. stock rally after Fed decisionsJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Will Alzamend Neuro Inc. stock reach all time highs in 2025Exit Point & Daily Technical Forecast Reports - newser.com
Alzamend completes clinical portion of phase II trial for lithium therapy - Investing.com Nigeria
Published on: 2025-11-19 13:20:00 - newser.com
Alzamend Neuro Inc (ALZN) 財務データ
収益
当期純利益
現金流量
EPS
Alzamend Neuro Inc (ALZN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Horne William B. | Director |
Dec 19 '25 |
Sale |
2.12 |
3,333 |
7,059 |
0 |
| McGrath Lynne Fahey | Director |
Oct 23 '25 |
Sale |
2.29 |
30 |
69 |
25 |
| AULT MILTON C III | Director |
Oct 08 '25 |
Sale |
2.44 |
101,394 |
247,158 |
28,657 |
| AULT MILTON C III | Director |
Oct 09 '25 |
Sale |
2.32 |
20,397 |
47,390 |
8,260 |
| AULT MILTON C III | Director |
Oct 06 '25 |
Sale |
2.45 |
82,033 |
201,268 |
26,227 |
| AULT MILTON C III | Director |
Oct 07 '25 |
Sale |
2.49 |
57,379 |
142,954 |
68,848 |
| AULT MILTON C III | Director |
Oct 03 '25 |
Sale |
2.44 |
65,903 |
160,889 |
8,260 |
| AULT MILTON C III | Director |
Oct 01 '25 |
Sale |
2.35 |
36,777 |
86,378 |
94,849 |
| AULT MILTON C III | Director |
Oct 02 '25 |
Sale |
2.39 |
20,686 |
49,522 |
74,163 |
| AULT MILTON C III | Director |
Sep 29 '25 |
Sale |
2.31 |
38,324 |
88,490 |
35,192 |
0.60%
0.62%
大文字化:
|
ボリューム (24 時間):